Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and montanide ISA720 adjuvants

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 2, 2005, Pages 242-248

  Carvalho, Leonardo J M ^a   Alves, Francisco A ^a,c   Bianco Jr , Cesare ^a   Oliveira, Salma G ^d   Zanini, Graziela M ^b   Soe, Soe ^e   Druilhe, Pierre ^e   Theisen, Michael ^f   Muniz, José A P C ^c   Daniel Ribeiro, Cláudio T ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c National Primate Center   (Brazil)

^d INSTITUTO EVANDRO CHAGAS   (Brazil)

^e INSTITUT PASTEUR   (France)

^f Clinical Biochemistry   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; FREUND ADJUVANT; GLUTAMATE RICH PROTEIN; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 3; MONTANIDE ISA720; PARASITE ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GLUTAMATE RICH PROTEIN, PLASMODIUM; GLUTAMATE-RICH PROTEIN, PLASMODIUM; MANNITOL; MANNITYL OLEATE; MEROZOITE SURFACE PROTEIN 3, PLASMODIUM; OLEIC ACID; PROTOZOAL PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CEBIDAE; CONTROLLED STUDY; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EXPERIMENTAL INFECTION; FEMALE; IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; LACTOCOCCUS LACTIS; MALARIA; MALE; MONKEY; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM FUP STRAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SAIMIRI SCIUREUS; ANIMAL; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; METABOLISM;

ANIMALS; ANTIGENS, PROTOZOAN; FREUND'S ADJUVANT; LACTOCOCCUS LACTIS; MALARIA VACCINES; MALARIA, FALCIPARUM; MANNITOL; OLEIC ACIDS; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; SAIMIRI;

EID: 22044435930     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.2.242-248.2005     Document Type: Article

References (15)

1. Breman, J. G. 2001. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 64: 1-11.
2. Borre, M. B., B. M. Dziegel, Hogh, E. Petersen, K. Rieneck, R. Riley, J. F. Meis, M. Aikawa, K. Nakamura, M. Harada, A. Wind, P. H. Jakobsen, J. Cowland, S. Jepsen, N. H. Axelsen, and J. Vuust. 1991. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate-rich protein (GLURP) expressed in both the pre-erythrocytic and erythrocytic stages of the vertebrate life cycle. Mol. Biochem. Parasitol. 49:119-132.
3. Carvalho, L. J. M., F. A. Alves, S. G. Oliveira, R. D. R. Valle, A. A. M. Fernandes, J. A, P. C. Muniz, and C. T. Daniel-Ribeiro. 2003. Severe anemia affects both splenectomized and non-splenectomized Plasmodium falciparum-infected Aotus infulatus monkeys. Mem. Inst. Oswaldo Cruz. 98:679-686.
4. Carvalho, L. J. M., C. T. Daniel-Ribeiro, and H. Goto. 2002. Malaria vaccine: candidate antigens, mechanisms, constraints, and prospects. Scand. J. Immunol. 56:327-343.
5. Carvalho, L. J., S. G. Oliveira, M. Theisen, F. A. Alves, M. C. Andrade, G. M. Zanini, M. C. Brigido, C. Oeuvray, M. M. Povoa, J. A. Muniz, P. Druilhe, and C. T. Daniel-Ribeiro. 2004. Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand. J. Immunol. 59:363-372.
6. Fandeur, T., and W. Chalvet. 1998. Variant- and strain-specific immunity in Saimiri infected with Plasmodium falciparum. Am. J. Trop. Med. Hyg. 58: 225-231.
7. Herrera, S., B. L. Perlaza, A. Bonelo, and M. Arevalo-Herrera. 2002. Aotus monkeys: their great value for antimalaria vaccines and drug testing. Int. J. Parasitol. 32:1625-1635.
8. Hisaeda, H., A. Saul, J. J. Reece, M. C. Kennedy, C. A. Long, L. H. Miller, and A. W. Stowers. 2002. Merozoite surface protein 3 and protection against malaria in Aotus monkeys. J. Infect. Dis. 185:657-664.
9. Kumar, S., W. Collins, A. Egan, A. Yadava, O. Garraud, M. J. Blackman, J. A. G. Patino, C. Diggs, and D. C. Kaslow. 2000. Immunogenicity and efficacy in Aotus monkey of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C-terminal of merozoite surface protein 1. Infect. Immun. 68:2215-2223.
10. Oeuvray, C., H. Bouharoun-Tayoun, H. Grass-Masse, E. Bottius, T. Kaidoh, M. Aikawa, M. Filgueira, C. Tartar, and P. Druilhe. 1994. Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by co-operation with blood monocytes. Blood 84:1594-1602.
11. Theisen, M., D. Dodoo, A. Toure-Balde, S. Soe, G. Corradin, K. K. Koram, J. A. Kurtzhals, L. Hviid, T. Theander, B. Akanmori, M. Ndiaye, and P. Druilhe. 2001. Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect. Immun. 69:5223-5229.
12. Theisen, M., S. Soe, K. Brunstedt, F. Follmann, L. Bredmose, H. Israelsen, S. M. Madsen, and P. Druilhe. 2004. A Plasmodium falciparum GLURP-MSP3 chimeric protein: expression in Lactococcus lactis, immunogenicity, and induction of biologically active antibodies. Vaccine 22:1188-1198.
13. Theisen, M., S. Soe, S. G. Jessing, L. M. Okkels, S. Danielsen, C. Oeuvray, P. Druilhe, and S. Jepsen. 2001. Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Vaccine 19:204-212.
14. Theisen, M., S. Soe, C. Oeuvray, A. W. Thomas, J. Vuust, S. Danielsen, S. Jepsen, and P. Druilhe. 1998. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect. Immun. 66:11-17.
15. World Health Organization. 1988. Memorandum from a W.H.O. meeting: role of non-human primates in malaria vaccine development. Bull. W.H.O. 66:719-728